---
title: "NVIDIA concept stocks collectively rose, Recursion Pharmaceuticals increased by over 12%, WeRide ros"
description: "NVIDIA concept stocks collectively rose, Recursion Pharmaceuticals increased by over 12%, WeRide rose by over 7%, and CoreWeave rose by over 4%"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261283559.md"
published_at: "2025-10-15T14:07:53.000Z"
---

# NVIDIA concept stocks collectively rose, Recursion Pharmaceuticals increased by over 12%, WeRide ros

> NVIDIA concept stocks collectively rose, Recursion Pharmaceuticals increased by over 12%, WeRide rose by over 7%, and CoreWeave rose by over 4%

NVIDIA concept stocks collectively rose, Recursion Pharmaceuticals increased by over 12%, WeRide rose by over 7%, and CoreWeave rose by over 4%

### Related Stocks

- [NVDA.US - NVIDIA](https://longbridge.com/en/quote/NVDA.US.md)
- [RXRX.US - Recursion Pharmaceuticals](https://longbridge.com/en/quote/RXRX.US.md)
- [WRD.US - WeRide](https://longbridge.com/en/quote/WRD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Is Sandisk the New Nvidia? | Sandisk is evolving from its traditional flash memory market to become a key player in AI data centers, similar to Nvidi | [Link](https://longbridge.com/en/news/276076737.md) |
| WeRide Just Hit the Roads in Dubai. Should You Buy WRD Stock Now? | WeRide Just Hit the Roads in Dubai. Should You Buy WRD Stock Now? | [Link](https://longbridge.com/en/news/269896363.md) |
| Tranquility Partners LLC Has $8.60 Million Holdings in NVIDIA Corporation $NVDA | Tranquility Partners LLC increased its holdings in NVIDIA Corporation (NASDAQ: NVDA) by 10% in Q3, owning 46,069 shares  | [Link](https://longbridge.com/en/news/275589681.md) |
| Prediction: This AI Stock Will Soar After Feb. 25. Here's Why. | Nvidia (NVDA) shares have faced a 2% decline over the past three months due to geopolitical tensions and concerns about  | [Link](https://longbridge.com/en/news/275701772.md) |
| Nvidia Stock Forecast Gets a Boost? Top Analyst Turns More Bullish Ahead of Q4 Earnings | Nvidia (NVDA) stock received a boost from UBS analyst Timothy Arcuri, who raised his price target to $245 from $235 ahea | [Link](https://longbridge.com/en/news/275702966.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.